DNMT1 and cancer: DNA methylation inhibitors characterized by nucleoside analogs with a modified cytosine ring can be incorporated into newly synthesized DNA or RNA and then covalently bind with DNMTs, resulting in hypomethylation of newly synthesized DNA.[14] Small molecule inhibitors of DNMT (DNMTi), also known as hypomethylation agents, are the most common epigenetic therapy for cancer.